Shilei Xu - Publications

Clinical outcomes with first-line tislelizumab plus lenvatinib in unresectable hepatocellular carcinoma: a retrospective analysis.

Journal: PeerJ

Published: September 02, 2025

Dynamics changes of spleen volume predict survival outcomes in unresectable hepatocellular carcinoma treated with tislelizumab plus lenvatinib.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 20, 2025

Interleukin-6 classic and trans-signaling utilize glucose metabolism reprogramming to achieve anti- or pro-inflammatory effects.

Journal: Metabolism: clinical and experimental

Published: December 15, 2023

Single-cell transcriptomics reveals immune infiltrate in sepsis.

Journal: Frontiers in pharmacology

Published: December 28, 2022

Upregulation of NUAK2: A novel prognostic marker in breast cancer.

Journal: Histology and histopathology

Published: November 28, 2022

Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro.

Journal: Emerging microbes & infections

Published: January 06, 2022

Identification of a novel four-gene diagnostic signature for patients with sepsis by integrating weighted gene co-expression network analysis and support vector machine algorithm.

Journal: Hereditas

Published: September 09, 2021

Erianin: A Direct NLRP3 Inhibitor With Remarkable Anti-Inflammatory Activity.

Journal: Frontiers in immunology

Published: July 12, 2021

Identification of a 5-Gene-Based Scoring System by WGCNA and LASSO to Predict Prognosis for Rectal Cancer Patients.

Journal: Analytical cellular pathology (Amsterdam)

Published: October 21, 2020

Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.

Journal: Translational cancer research

Published: June 07, 2020

Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.

Journal: The Journal of biological chemistry

Published: September 06, 2018

Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-κB Signaling.

Journal: BioMed research international

Published: August 28, 2018